Details for 2017840420
Up to date per 02.04.2026
Actions
Details for 2017840420
Granted/Registered
European Patent
19.06.2019 A
09.02.2022 B1
08.08.2016
US
201662372092 P
23.06.2017
US
201762524286 P
A61K 38/50 20060101AFI20210723BHEP
Owner
Immedica Pharma ABSolnavägen 3H113 63 StockholmSE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
LOWE, David8524 Parismina Lane Austin, TX 78735US
ROWLINSON, Scott, W.700 Grey Fox Court Austin, TX 78746US
ALTERS, Susan3372 Kipling Street Palo Alto, CA 94306US
AGNELLO, Giulia203 W. 39th Street Apt. 305 Austin, TX 78751-5023US
Information about Fees